BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32156917)

  • 1. [A Case of Gastric Cancer with Continued Progression-Free Survival Even after Total Gastrectomy and Nivolumab Therapy].
    Fujii H; Choda Y; Kubota T; Ishida M; Sato D; Sumitani D; Yoshimitsu M; Nakano K; Harano M; Matsukawa H; Idani H; Shiozaki S; Okajima M
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2318-2320. PubMed ID: 32156917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Multiple Lymph Node Metastases Treated with Nivolumab after an Adrenalectomy for Solitary Adrenal Metastasis of Gastric Cancer after a Gastrectomy].
    Nakai M; Ichisawa A; Yamada T; Kimura T; Yonaiyama S; Jin H; Tokura T; Aoki K; Kawashima H; Toyoki Y; Endo M
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2434-2436. PubMed ID: 32156956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Unresectable Advanced Gastric Neuroendocrine Cell Carcinoma Treated with Nivolumab].
    Yoshioka R; Nagase H; Noguchi K; Hamabe A; Hirota M; Oshima K; Tanida T; Ogino T; Tomimaru Y; Kawase T; Noura S; Imamura H; Iwasawa T; Akagi K; Ando H; Tamura H; Adachi S; Dono K
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1530-1532. PubMed ID: 30382068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Recurrent Gastric Cancer with Durable Complete Response after Short-Term Nivolumab Therapy].
    Yamamichi K; Yamada M; Sumiyama F; Yamamoto N; Hashimoto Y; Satake R; Hatta M; Sakaguchi T; Kotsuka M; Tokuhara K; Inoue K; Sekimoto M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2052-2054. PubMed ID: 35045490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperprogressive Disease during Treatment with Nivolumab for Recurrence of Gastric Cancer].
    Takeoka T; Okada K; Matsuno H; Konishi K; Ota H; Yokoyama S; Fukunaga M; Kobayashi K
    Gan To Kagaku Ryoho; 2020 Jan; 47(1):165-167. PubMed ID: 32381893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
    Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
    World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with Nivolumab in the Treatment of Metastatic Gastric Cancer].
    Takao C; Matsuhashi N; Murase Y; Yasufuku I; Tanahashi T; Yamaguchi K; Matsui S; Imai H; Tanaka Y; Takahashi T; Yoshida K
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1546-1548. PubMed ID: 30382073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of gastric cancer with delayed onset of tumor reduction effect by nivolumab therapy.
    Satoyoshi R; Muto O; Masuda A; Kotanagi K; Kichiraku T; Kudoh K; Sawada T; Miyazawa H; Kotanagi H
    Clin J Gastroenterol; 2019 Feb; 12(1):15-19. PubMed ID: 30206777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Curative Resection of the Local Advanced Gastric Cancer after SOX plus Nivolumab Chemotherapy, and the Pathological Diagnosis Was Complete Response].
    Harada K; Fukunaga K; Kashimoto K; Yamaguchi A
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1712-1714. PubMed ID: 38303182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advanced Gastric Cancer with Tumor Shrinkage Persisting after the Discontinuation of Nivolumab-A Case Report].
    Sato I; Nakaya N; Obara Y; Ueno S; Nakajima H
    Gan To Kagaku Ryoho; 2020 Dec; 47(12):1715-1717. PubMed ID: 33342990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Brain Metastasis of Gastric Cancer Successfully Treated with Nivolumab].
    Omoto K; Urakami H; Seki S; Tanizawa S; Isobe Y
    Gan To Kagaku Ryoho; 2021 May; 48(5):713-716. PubMed ID: 34006721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Advanced Gastric Cancer Treated with Conversion Surgery followed by Nivolumab Combination Chemotherapy].
    Sekino N; Natsume T; Tanaka H; Kainuma O; Sato Y; Note H; Yoshioka T; Kamata T; Odera H; Uchiyama M; Maruyama T; Takahashi H; Hirano S
    Gan To Kagaku Ryoho; 2024 Apr; 51(4):417-420. PubMed ID: 38644309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.
    Masuda K; Shoji H; Nagashima K; Yamamoto S; Ishikawa M; Imazeki H; Aoki M; Miyamoto T; Hirano H; Honma Y; Iwasa S; Okita N; Takashima A; Kato K; Boku N
    BMC Cancer; 2019 Oct; 19(1):974. PubMed ID: 31638948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Long Survival with Hilar Lymph Node Metastasis from Gastric Cancer Successfully Treated with Nivolumab Immunotherapy].
    Okada K; Takeoka T; Kobayashi K; Fukunaga M
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2315-2317. PubMed ID: 32156916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Conversion Surgery for Unresectable Advanced Gastric Cancer of Which Metastatic Site Was Disappear by Chemotherapy but the Primary Site Was Enlarged after Five Years].
    Nomura A; Akamaru Y; Nishida K; Mori S; Yasuyama A; Nomura M; Yoshikawa Y; Tamai K; Takiuchi D; Hamakawa T; Tei M; Tsujie M
    Gan To Kagaku Ryoho; 2024 Apr; 51(4):473-475. PubMed ID: 38644326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Evaluation of the Efficacy and Adverse Effects of Nivolumab Treatment for Patients with Advanced Gastric Cancer].
    Ohta A; Komatsu S; Tsuji R; Tanaka S; Kumano T; Imura K; Shimomura K; Ikeda J; Taniguchi F; Doi T; Yamada S; Tomatsuri N; Yoshida N; Shioaki Y
    Gan To Kagaku Ryoho; 2020 Apr; 47(4):725-727. PubMed ID: 32389997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Esophagogastric Junction Cancer Treated Successfully with Conversion Surgery after Complete Response to Nivolumab Treatment].
    Yamazaki K; Taniguchi K; Yamane M; Hattori Y; Koizumi A; Shigehara F; Takashima J; Sugimoto H; Miura F; Matsutani N; Kobayashi H
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2121-2123. PubMed ID: 35045512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Case of Advanced Gastric Cancer in Which Tumor Relapse Was Observed after Discontinuation of Nivolumab Due to Complete Response, and for Which Re-Administration Was Initiated].
    Nishida K; Yagi H; Mizumoto R; Haeno M; Mori S; Nomura M; Yasuyama A; Yoshikawa Y; Sueda T; Matsumura T; Koga C; Miyagaki H; Tei M; Tsujie M; Akamaru Y
    Gan To Kagaku Ryoho; 2023 Mar; 50(3):343-345. PubMed ID: 36927904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Initially Unresectable Advanced Gastric Cancer Radically Resected by Conversion Surgery after Nivolumab Immunotherapy].
    Koizumi N; Kashiwagi S; Ogino S; Kamada Y; Fujiki H; Sakakura C
    Gan To Kagaku Ryoho; 2020 Nov; 47(11):1624-1626. PubMed ID: 33268741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.
    Bozorgmehr F; Hommertgen A; Krisam J; Lasitschka F; Kuon J; Maenz M; Huber PE; König L; Kieser M; Debus J; Thomas M; Rieken S
    BMC Cancer; 2019 Nov; 19(1):1074. PubMed ID: 31703637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.